The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32

Citation
N. Spieker et al., The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32, GENOMICS, 71(2), 2001, pp. 214-221
Citations number
37
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENOMICS
ISSN journal
08887543 → ACNP
Volume
71
Issue
2
Year of publication
2001
Pages
214 - 221
Database
ISI
SICI code
0888-7543(20010115)71:2<214:TMOIHE>2.0.ZU;2-C
Abstract
Neuroblastoma is an embryonal tumor originating from neural crest-derived c ells. Here we present the serendipitous cloning of amplified sequences of c hromosome 2p15 in neuroblastoma cell line IMR32. The amplified region was a nalyzed for oncogene activation using a SAGE (serial analysis of gene expre ssion) library of IMR32. SAGE permits a quantitative analysis of all transc ripts of a tissue or cell line. The expression of genes and ESTs mapping wi thin a 30-cR region covering the amplicon was compared to 4 additional SAGE libraries of neuroblastomas and 12 SAGE libraries of other tissues in the CGAP databases. The IMR32 SAGE database revealed increased expression of th e MEIS1 oncogene, whereas other SAGE libraries showed little or no IMEIS1 e xpression. MEIS1 turned out to be highly amplified and overexpressed in IMR 32. Analysis of 24 neuroblastoma cell Lines and 22 tumors showed high-level expression in about 25% of the cases. The MEIS1 homeobox protein forms a c omplex with the HOXA9 and PBX proteins that are implicated in human leukemi a. MEIS1 is a target of retroviral insertion in murine leukemia. This is th e first report of a MEIS1 amplification and high expression levels in human cancer and the first time that identification of a candidate target of amp lification is facilitated by high-throughput mRNA expression profiling. (C) 2001 Academic Press.